Ftse Mib
34.151,41
-0,27%
DAX
18.498,38
0,32%
S&P 500
5.187,67
0,00%
NASDAQ
16.302,76
-0,18%
Bitcoin
61.289,15
0,17%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Foghorn Therapeutics Inc (FHTX) Foghorn Therapeutics Inc (FHTX) Notizie

Foghorn Therapeutics Inc

FHTX
5,98
0,35 (6,22%)
09 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/5/202422:54EDGAR2Form 8-K - Current report
06/5/202413:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202413:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/5/202413:03EDGAR2Form 8-K - Current report
07/3/202413:11EDGAR2Form 8-K - Current report
07/3/202413:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/2/202413:04EDGAR2Form 8-K - Current report
25/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:09EDGAR2Form 8-K - Current report
08/1/202413:04EDGAR2Form 8-K - Current report
03/1/202422:18EDGAR2Form 8-K - Current report
28/11/202301:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202312:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
02/11/202312:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202312:03EDGAR2Form 8-K - Current report
01/11/202315:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
11/9/202312:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
08/9/202313:04EDGAR2Form 8-K - Current report
05/9/202314:00GLOBEFoghorn Therapeutics Announces Participation in Upcoming..
31/8/202313:04EDGAR2Form 8-K - Current report
31/8/202313:00GLOBEFoghorn Therapeutics Announces First Patient Dosed in Phase..
29/8/202315:00PRNUSInvaio achieves first registration for citrus greening..
18/8/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:08EDGAR2Form 8-K - Current report
08/8/202313:05EDGAR2Form 8-K - Current report
08/8/202313:00GLOBEFoghorn Therapeutics Announces Chief Medical Officer..
04/8/202313:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202313:05EDGAR2Form 8-K - Current report
04/8/202313:00GLOBEFoghorn Therapeutics Provides Second Quarter 2023 Financial..
28/6/202313:00GLOBEFoghorn Therapeutics Announces Clinical Data from Phase 1..
05/6/202314:07DJNFoghorn Therapeutics Shares Rally Premarket as FDA Lifts..
16/5/202312:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..
Apertura: 5,51 Min: 5,51 Max: 5,97
Chiusura: 5,63

La tua Cronologia

NASDAQ
FHTX
Foghorn Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network